Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cognitive dysfunction: A growing link between diabetes and Alzheimer's disease
Kavya Jash, Piyush Gondaliya, Prathibha Kirave, et al.
Drug Development Research (2019) Vol. 81, Iss. 2, pp. 144-164
Closed Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

Dietary polyphenols: regulate the advanced glycation end products-RAGE axis and the microbiota-gut-brain axis to prevent neurodegenerative diseases
Yueqin Li, Yao Peng, Yingbin Shen, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 29, pp. 9816-9842
Closed Access | Times Cited: 103
Molecular mechanisms underlying hyperglycemia associated cognitive decline
Mrinal Gupta, Shivani Pandey, Mohammad Rumman, et al.
IBRO Neuroscience Reports (2022) Vol. 14, pp. 57-63
Open Access | Times Cited: 53
Inhibition of ferroptosis through regulating neuronal calcium homeostasis: An emerging therapeutic target for Alzheimer’s disease
Yiran Sun, Chenchen Yan, Libo He, et al.
Ageing Research Reviews (2023) Vol. 87, pp. 101899-101899
Closed Access | Times Cited: 26
Pathological Mechanisms Linking Diabetes Mellitus and Alzheimer’s Disease: the Receptor for Advanced Glycation End Products (RAGE)
Yanyan Kong, Fushuai Wang, Jiao Wang, et al.
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 60
Phytotherapy: A promising approach for the treatment of Alzheimer's disease
Ogbodo Onyebuchi John, Ihim Stella Amarachi, Chinazom Precious Agbo, et al.
Pharmacological Research - Modern Chinese Medicine (2021) Vol. 2, pp. 100030-100030
Open Access | Times Cited: 46
Downregulation of Circular RNA PSEN1 ameliorates ferroptosis of the high glucose treated retinal pigment epithelial cells via miR-200b-3p/cofilin-2 axis
Zhaoliang Zhu, Peng Duan, Huping Song, et al.
Bioengineered (2021) Vol. 12, Iss. 2, pp. 12555-12567
Open Access | Times Cited: 45
Exercise as a Therapeutic Intervention in Gestational Diabetes Mellitus
Κωνσταντίνα Δίπλα, Andreas Zafeiridis, Gesthimani Mintziori, et al.
Endocrines (2021) Vol. 2, Iss. 2, pp. 65-78
Open Access | Times Cited: 43
Relationship between glycemic control and cognitive impairment: A systematic review and meta-analysis
Yufeng Lin, Zhongying Gong, Chunchao Ma, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 21
True or false? Alzheimer’s disease is type 3 diabetes: Evidences from bench to bedside
Yong Peng, Shun-yu Yao, Quan Chen, et al.
Ageing Research Reviews (2024) Vol. 99, pp. 102383-102383
Open Access | Times Cited: 7
Modulation of MicroRNAs as a Potential Molecular Mechanism Involved in the Beneficial Actions of Physical Exercise in Alzheimer Disease
Alex Cleber Improta‐Caria, Carolina Kymie Vasques Nonaka, Bruno Raphael Ribeiro Cavalcante, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 4977-4977
Open Access | Times Cited: 49
Hypertension and Age-Related Cognitive Impairment: Common Risk Factors and a Role for Precision Aging
Meredith Hay, Carol A. Barnes, Matt Huentelman, et al.
Current Hypertension Reports (2020) Vol. 22, Iss. 10
Open Access | Times Cited: 41
Estrogenic Plants: to Prevent Neurodegeneration and Memory Loss and Other Symptoms in Women After Menopause
Valentina Echeverrı́a, Florencia Echeverria, George E. Barreto, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 36
Posttranscriptional Regulation of Insulin Resistance: Implications for Metabolic Diseases
Ana Pérez-García, Marta Torrecilla-Parra, Mario Fernández-de Frutos, et al.
Biomolecules (2022) Vol. 12, Iss. 2, pp. 208-208
Open Access | Times Cited: 27
Emerging Pathophysiological Mechanisms Linking Diabetes Mellitus and Alzheimer’s Disease: An Old Wine in a New Bottle
Vishvas N. Patel, Mehul R. Chorawala, Maitri B. Shah, et al.
Journal of Alzheimer s Disease Reports (2022) Vol. 6, Iss. 1, pp. 349-357
Open Access | Times Cited: 25
Bitter yet beneficial: The dual role of dietary alkaloids in managing diabetes and enhancing cognitive function
Majed Abdo Alkanad, Umme Hani, H. V. Annegowda, et al.
BioFactors (2024) Vol. 50, Iss. 4, pp. 634-673
Closed Access | Times Cited: 5
In Vitro Astroglial Dysfunction Induced by Neurotoxins: Mimicking Astrocytic Metabolic Alterations of Alzheimer’s Disease
Jéssica Taday, Fernanda Fróes, Marina Seady, et al.
Metabolites (2024) Vol. 14, Iss. 3, pp. 151-151
Open Access | Times Cited: 5
ZiBuPiYin Recipe Prevented and Treated Cognitive Decline in ZDF Rats With Diabetes-Associated Cognitive Decline via Microbiota–Gut–Brain Axis Dialogue
Tingting Bi, Ruiqi Feng, Libin Zhan, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 28
Metformin use is associated with a reduced risk of cognitive impairment in adults with diabetes mellitus: A systematic review and meta-analysis
Jiahao Zhang, Xinyang Zhang, Yanqiu Sun, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 21
Communal interaction of glycation and gut microbes in diabetes mellitus, Alzheimer's disease, and Parkinson's disease pathogenesis
Rahul Patil, Rashmi S. Tupe
Medicinal Research Reviews (2023) Vol. 44, Iss. 1, pp. 365-405
Closed Access | Times Cited: 12
Association of metabolic dysfunction with cognitive decline and Alzheimer's disease: A review of metabolomic evidence
Meysam Amidfar, Gholamreza Askari, Yong‐Ku Kim
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 128, pp. 110848-110848
Closed Access | Times Cited: 11
The role of traditional Chinese medicine in the treatment of cognitive dysfunction in type 2 diabetes
Jinni Meng, Yafei Zhu, Huixia Ma, et al.
Journal of Ethnopharmacology (2021) Vol. 280, pp. 114464-114464
Closed Access | Times Cited: 27
Identification of Flavonoid C-Glycosides as Promising Antidiabetics Targeting Protein Tyrosine Phosphatase 1B
Athika Rampadarath, Fatai Oladunni Balogun, Charlene Pillay, et al.
Journal of Diabetes Research (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 17
Metformin: The Winding Path from Understanding Its Molecular Mechanisms to Proving Therapeutic Benefits in Neurodegenerative Disorders
Laura Mihaela Isop, Andrea Elena Neculau, Radu Necula, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1714-1714
Open Access | Times Cited: 10
Interaction of aerobic exercise and crocin improves memory, learning and hypocampic tau and neurotrophins gene expression in rats treated with trimethytin as a model of Alzheimer’s disease
Mehrzad Moghadasi, Fatemeh Akbari, Parisa Najafi
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 3
Oral phytate supplementation on the progression of mild cognitive impairment, brain iron deposition and diabetic retinopathy in patients with type 2 diabetes: a concept paper for a randomized double blind placebo controlled trial (the PHYND trial)
Antelm Pujol, Pilar Sanchís, María Isabel Tamayo, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top